On Demand

Weighing Benefit and Risk When Prescribing Opioids in 2023 - DEA Training

Name: Weighing Benefit and Risk When Prescribing Opioids in 2023 - DEA Training
Price: 45.00 USD
Availability: InStock
Rating: 4.44 (9 reviews)

Total Credits: 1.25 including 1.25 AOA Category 1-A Credit(s), 1.25 AMA PRA Category 1 Credit(s)™

Average Rating:: 9
State Associations:: MOA - Michigan
Faculty:: David Neff DO
Duration:: 1 hour 10 minutes
Expiration:: Access for 30 day(s) after purchase.

Price
$45.00 - Base Price

Description

David Neff, DO

Learning Objectives:
1. The challenges that impact the ability to appropriately manage opioids in 2023 go back at least six millennia.
2. The overdose landscape in 2023.
3. What's happening with current prescription trends and rates of patient misuse.

Credits Offered:
1.25 AOA Category 1-A Credit
1.25 AMA PRA Category 1 Credit(s)™

Accreditation Statements

The Michigan Osteopathic Association is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The Michigan Osteopathic Association designates this activity for a maximum of 1.25 AOA Category 1-A Credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.

MyMichigan Health is accredited by the Michigan State Medical Society (MSMS) to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint Providership of MyMichigan Health and Michigan Osteopathic Association.

Questions? Contact MOA staff

CME information at www.domoa.org/cmeinfo

Handouts

Faculty

David Neff DO Related Seminars and Products

Dr. David Neff is currently the COO/CMO at Redicare in Okemos, MI and Grand River Family Care, a combined urgent care and family medicine practice. He graduated from MSU College of Osteopathic Medicine and in 1980 where he received the MOA Distinguished Student Award and the Fred Mitchell Award for Excellence in Osteopathic Manipulative Therapy (OMT). He has been on clinical faculty in the MSUCOM Department of Family and Community Medicine since 1981. He is a member of the American Osteopathic Association and the Michigan Osteopathic Association. He is board certified by American College of Osteopathic Family Physicians and completed a two-year fellowship in Osteopathic Manual Medicine and Clinical Biomechanics.

Dr. Neff has spent his 41-year career caring for patients with spine and spinal cord conditions including those with severe intractable and uncurable pain. He utilizes manual medicine and other multimodal team-based approaches. He also has extensive background in the pharmacologic pain management. He has been studying the impact of the opioid mortality crisis since 2010. He has chaired several P&T Committees and Drug Utilization Review Boards. He was a founding member of the Michigan Health Society Opioid Safety Collaborative and the Michigan Osteopathic Association’s Presidential Ad Hoc Committee to address the opioid crisis since their inception in 2016. While performing roles in private practice, academia, government, and the pharmaceutical industry, Dr. Neff has been involved in large scale health systems strategy and design projects for chronic pain conditions and several other disease states. He has worked on several projects within the D.C. beltway with the FDA, CDC, CMS, PCORI, & the NQF.

Reviews

5
4
3
2
1